Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liquid Biopsy to Distinguish Malignant From Benign Pulmonary Nodules and to Monitor Response to Therapy

NCT05462795 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT05462795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05462795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liquid Biopsy to Distinguish Malignant From Benign Pulmonary Nodules and to Monitor Response to Therapy
Lead sponsor
University of Arizona
Phase
Observational
Overall status
Completed
Start date
August 2, 2022
Completion date
March 22, 2024
Enrollment
171 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non small-cell lung cancer